Skip to main content
SpringerLink
Log in

Ist Mitomycin C als Adjuvans zur Trabekulektomie stets erforderlich?

Is mitomycin C always necessary as an adjuvant to trabeculectomy?

  • Leserbriefe
  • Published:
Die Ophthalmologie Aims and scope Submit manuscript

A Leserbriefe to this article was published on 08 September 2023

The Original Article was published on 13 April 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Notes

  1. Zur Entwicklung einer Katarakt nach Trabekulektomie: Es ist nicht die Anwendung von Mitomycin, welches eine Katarakt induziert; jeglicher Einfluss auf die Strömung des Kammerwassers im Auge ist kataraktogen, insbesondere die meist intraoperativ durchgeführte Iridektomie (korrelierend auch zur Größe der Iridektomie) [2, 3].

Literatur

  1. Prokosch V, Dietlein T, Pfeiffer N (2023) Neue und alte Verfahren der Glaukomchirurgie im Vergleich : Trabekulektomie, PreserFlo und XEN [Comparison of new and old procedures in glaucoma surgery : Trabeculectomy, Preserflo and XEN]. Ophthalmologie 120(4):350–357. https://doi.org/10.1007/s00347-023-01837-1 (Epub 2023 Apr 13. PMID: 37052708)

    Article  PubMed  Google Scholar 

  2. Rohrbach JM, Dzhelebov D, Voykov B (2023) Zur Pathogenese des akuten Winkelblocks: die Iris als Schwamm [The pathogenesis of acute angle block: the iris as a sponge]. Ophthalmologie 120(3):328–329. https://doi.org/10.1007/s00347-023-01818-4 (Epub 2023 Feb 8. PMID: 36752795)

    Article  PubMed  Google Scholar 

  3. Feiner L, Piltz-Seymour JR (2003) Collaborative initial glaucoma treatment study. Collaborative initial glaucoma treatment study: a summary of results to date. Curr Opin Ophthalmol 14(2):106–111. https://doi.org/10.1097/00055735-200304000-00010 (PMID: 12698052)

    Article  PubMed  Google Scholar 

  4. Wallin Ö, Al-ahramy AM, Lundström M, Montan P (2014) Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol 92(5):426–431. https://doi.org/10.1111/aos.12257 (Epub 2013 Sep 11. PMID: 24020653)

    Article  PubMed  Google Scholar 

  5. Zahid S, Musch DC, Niziol LM, Lichter PR, Collaborative Initial Glaucoma Treatment Study Group (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155(4):674–680, 680.e1. https://doi.org/10.1016/j.ajo.2012.10.017 (Epub 2012 Dec 13. PMID: 23246272; PMCID: PMC3608803)

    Article  PubMed  Google Scholar 

  6. Yamamoto T, Sawada A, Mayama C, Araie M, Ohkubo S, Sugiyama K, Kuwayama Y, Collaborative Bleb-Related Infection Incidence and Treatment Study Group. (2014) The 5‑year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology 121(5):1001–1006. https://doi.org/10.1016/j.ophtha.2013.11.025 (Epub 2014 Jan 11. PMID: 24424248)

    Article  PubMed  Google Scholar 

  7. Ohtomo K, Mayama C, Ueta T, Nagahara M (2015) Outcomes of late-onset bleb-related endophthalmitis treated with pars plana vitrectomy. J Ophthalmol 2015:923857. https://doi.org/10.1155/2015/923857 (Epub 2015 Oct 1. PMID: 26495137; PMCID: PMC4606135)

    Article  PubMed  PubMed Central  Google Scholar 

  8. Joshi AB, Parrish RK 2nd, Feuer WF (2005) 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 14(2):172–174. https://doi.org/10.1097/01.ijg.0000151684.12033.4d (PMID: 15741822)

    Article  PubMed  Google Scholar 

  9. Mirshahi A, Lashay A, Mehrabi Bahar MR, Abrishami M (2018) Consequences of inadvertent intravitreal Mitomycin C injection. Int J Retin Vitreous 12(4):7. https://doi.org/10.1186/s40942-018-0110-6 (PMID: 29449964; PMCID: PMC5808448)

    Article  Google Scholar 

  10. Zacharia PT, Deppermann SR, Schuman JS (1993) Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 116(3):314–326. https://doi.org/10.1016/s0002-9394(14)71349-2 (PMID: 8357056)

    Article  CAS  PubMed  Google Scholar 

  11. Kompa S, Redbrake C, Arend O, Remky A (2004) Defektverschluss mit Sklerainterponaten [Defect closure with scleral grafts]. Klin Monbl Augenheilkd 221(10):867–871. https://doi.org/10.1055/s-2004-813656 (PMID: 15499523)

    Article  CAS  PubMed  Google Scholar 

  12. Mutsch YA, Grehn F (2000) Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC). Graefes Arch Clin Exp Ophthalmol 238(11):884–891. https://doi.org/10.1007/s004170000139 (PMID: 11148811)

    Article  CAS  PubMed  Google Scholar 

  13. Lindemann F, Plange N, Kuerten D, Schimitzek H, Koutsonas A (2017) Three-year follow-up of trabeculectomy with 5‑Fluorouracil. Ophthalmic Res 58(2):74–80. https://doi.org/10.1159/000464446 (Epub 2017 Apr 28. PMID: 28449000)

    Article  CAS  PubMed  Google Scholar 

  14. Lin ZJ, Li Y, Cheng JW, Lu XH (2012) Intraoperative mitomycin C versus intraoperative 5‑fluorouracil for trabeculectomy: a systematic review and meta-analysis. J Ocul Pharmacol Ther 28(2):166–173. https://doi.org/10.1089/jop.2011.0117 (Epub 2011 Oct 26. PMID: 22029538)

    Article  CAS  PubMed  Google Scholar 

  15. Singh K, Egbert PR, Byrd S, Budenz DL, Williams AS, Decker JH, Dadzie P (1997) Trabeculectomy with intraoperative 5‑fluorouracil vs mitomycin C. Am J Ophthalmol 123(1):48–53. https://doi.org/10.1016/s0002-9394(14)70991-2 (PMID: 9186096)

    Article  CAS  PubMed  Google Scholar 

  16. European Glaucoma Society (2021) Terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 105(Suppl 1):1–169. https://doi.org/10.1136/bjophthalmol-2021-egsguidelines (PMID: 34675001)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik Regensburg, Prüfeninger Str. 86, 93049, Regensburg, Deutschland

    Andreas Remky

  2. Augenzentrum am Annapark, 52477, Alsdorf, Deutschland

    Niklas Plange

  3. Klinik für Augenheilkunde, Uniklinik der RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland

    Niklas Plange

Authors
  1. Andreas Remky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niklas Plange
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Remky.

Ethics declarations

Interessenkonflikt

A. Remky und N. Plange geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Remky, A., Plange, N. Ist Mitomycin C als Adjuvans zur Trabekulektomie stets erforderlich?. Ophthalmologie 120, 1063–1064 (2023). https://doi.org/10.1007/s00347-023-01915-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-023-01915-4

Search

Navigation